Featured
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.Sanofi 12.13.19
-
Bio News | Breaking News | Facilities | Industry News | R&D
Amgen Selects Location For R&D Facility
Will be located in the South San Francisco biotechnology hub.Amgen 12.13.19
-
Breaking News | Clinical Trials | Industry News | Information Technology
Almac Group, Exostar Collaborate on IRT Experience
Enables users of Almac’s Interactive Response Technology to use Exostar’s credentialing, federation, and web-based Single Sign-On capabilities12.12.19
-
Breaking News | Clinical Trial Materials | Industry News
Catalent Launches Clinical Trial Planning Service
Aims to support trial sponsors with earlier, more proactive clinical supply chain planning12.12.19
-
Breaking News | CRO News | Facilities | Industry News
-
Breaking News | Facilities | Industry News
PCI Pharma Services Invests in Tredegar, UK Site
Doubles capacity to expand development and manufacturing capabilities.12.11.19
-
Breaking News | Promotions & Moves
Sharp Strengthens Senior Leadership Team
Walter Tyrrell appointed chief financial officer and Robert O’Beirn senior vice president and commercial directorSharp 12.11.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Avantor Boosts Biopharmaceutical Innovation in China
Opens innovation and customer support center in Shanghai.12.11.19
-
Breaking News | Collaborations & Alliances | Supply Chain
Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels
New RFID-labels ideal for broad array of pharmaceutical products and medical devices.Schreiner MediPharm 12.11.19
-
Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
Charles River, Bit Bio Enter Strategic Pact
Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale12.10.19
-
Breaking News | Drug Development | Industry News
Merck to Acquire ArQule for $2.7B
Gains ARQ 531, an oral BTK inhibitor in Phase II development for the treatment of B-cell malignancies12.10.19
-
Breaking News | Drug Development | Industry News
Sanofi Acquires Synthorx in $2.5B Deal
CA-based immuno-oncology company expands Sanofi's cancer and autoimmune pipeline12.10.19
-
Breaking News | Formulation Development | Industry News
Catalent, Bridge Therapeutics Execute Exclusive License Agreement
To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product12.10.19
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | R&D
Rutgers-led Team Launches Science and Medicine Research Initiative
Plans to hasten clinical trials, develop new therapies and train a new scientific workforce in the Garden State.12.09.19
-
Breaking News | Collaborations & Alliances
AbbVie, Scripps Collaborate on New Therapeutics
To develop new therapies for a range of diseases, including areas of oncology, immunology, neurology and fibrosis.12.09.19
- CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
- Stevanato, Duoject Enter Auto-injector Collaboration
- Thermo Fisher Bolsters China Presence
- C2 Pharma Expands API Portfolio
- CPhI’s 16th Pharma Awards Winners
- MilliporeSigma Licenses CRISPR Technology to Evotec
- West and SCHOTT Enter Packaging Partnership
- IDT Biologika, NIH Mfg. Contract Updated
- Parsolex Selects Bosch Packaging Technology for New cGMP Facility
- Lonza Selects Cryoport as Preferred Partner
- MilliporeSigma Launches New Sucrose Offering
- Novel Surfactant Excipient Improves Biologic Stability in Liquid Formulation
- Cell and Gene Therapy Landscape
- MilliporeSigma Licenses CRISPR Technology to Evotec
- MilliporeSigma Launches Parteck COAT Excipient
- AAPS PharmSci360 2019
- Lonza Selects Cryoport as Preferred Partner
- Vineti, WuXi AppTec Ink Personalized Therapy Management Platform Pact
- Catalent Biologics Launches GPExR Boost Cell Line Expression Technology
- Recipharm Divests Bioanalysis Biz
- Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
- Amgen Selects Location For R&D Facility
- Arctoris Opens Oxford R&D Facility
- Almac Group, Exostar Collaborate on IRT Experience
- Northwest Biotherapeutics Expands Management Team
- Catalent Launches Clinical Trial Planning Service
- Pelican BioThermal Achieves ISO Accreditation
- Luminer Appoints Pre-Press Manager
- Charles River Provides Access to Cosmic Antibody Library
- CatSci Expands Capabilities with Lab Expansion
November/December 2019
- Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
- Transitioning from Clinical Production to Commercial Manufacturing
- Clinical Trial Technology
- Regenerative Medicine: Overcoming the supply chain challenges
- The Future of the Pharmaceutical Supply Chain
- Challenges and Opportunities in Vaccines Drug Development
- Managing Partnerships: Sponsors & CDMOs
- Towards Sunset or a New Dawn?
- Biopharma Over 20 Years
Contract Service Directory
Search the Directories for A Company:
